RecruitingNCT01206920

The DC Cohort Longitudinal HIV Status Neutral Study

Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: The DC Cohort

Sponsor

George Washington University

Enrollment

19,000 participants

Start Date

Jan 1, 2011

Study Type

OBSERVATIONAL

Conditions

HIV AIDS

Summary

The goal of the DC Cohort is to establish a clinic-based city-wide longitudinal cohort that will describe clinical outcomes, and improve the quality of care for patients diagnosed with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) or at higher risk for acquiring HIV and receiving care in Washington, DC.

Eligibility

Plain Language Summary

Simplified for easier understanding

This long-term study follows HIV-positive patients and people at high risk of HIV in Washington, DC to understand how HIV care, prevention strategies (like PrEP), and treatment affect health outcomes over time. **You may be eligible if...** - You are HIV-positive and receiving care at one of the 12 participating DC clinics, and are 18 or older (or a minor who can independently seek HIV care) - OR you are HIV-negative but are taking HIV prevention medication (PrEP), have recently had a potential HIV exposure, have had a bacterial sexually transmitted infection in the past year, or inject drugs - OR you are requesting PrEP or post-exposure prevention at a clinic visit **You may NOT be eligible if...** - You are unable or unwilling to give informed consent - You are a minor (age 12-17) who does not know your HIV status Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.